The National Heart, Lung, and Blood Institute (NHLBI) awarded a $249,000 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The grant, awarded on February 21, 2025, will support research to elucidate the molecular mechanisms underlying airway secretory cell dysfunction in chronic obstructive pulmonary disease (COPD), a leading cause of death. The research aims to enhance the understanding of COPD pathogenesis, with a focus on small airway disease and emphysema, to inform the development of new diagnostic tools and therapeutic interventions. The Research Institute at Nationwide Children's Hospital will leverage its expertise in cellular, molecular, and translational research approaches to deliver the project, which is expected to be completed by January 31, 2028.
Generated 3/25/25, 3:36 AM